Pre-Procedural Glucose Levels and the Risk for Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography

Journal of the American College of Cardiology

Volumn 55, Issue 14, 2010, Pages 1433-1440

  Stolker, Joshua M ^a,b   McCullough, Peter A ^c   Rao, Seshu ^a,b   Inzucchi, Silvio E ^d   Spertus, John A ^a,b   Maddox, Thomas M ^e   Masoudi, Frederick A ^e   Xiao, Lan ^a   Kosiborod, Mikhail ^a,b  

^a SAINT LUKE S MID AMERICA HEART INSTITUTE   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^c WILLIAM BEAUMONT HOSPITAL   (United States)

^d YALE UNIVERSITY   (United States)

^e UNIVERSITY OF COLORADO   (United States)

Author keywords

acute kidney injury; contrast nephropathy; coronary angiography; diabetes; glucose; myocardial infarction

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BICARBONATE; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; CONTRAST MEDIUM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPERGLYCEMIC AGENT; INSULIN; NITRATE; TICLOPIDINE;

ACUTE HEART INFARCTION; ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CLINICAL TRIAL; COHORT ANALYSIS; CONTRAST INDUCED ACUTE KIDNEY INJURY; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DIABETES MELLITUS; DIAGNOSTIC TEST; DRUG RELEASE; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HIGH RISK PATIENT; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; RADIATION HAZARD; RISK ASSESSMENT; RISK FACTOR;

AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; FEMALE; HUMANS; KIDNEY FAILURE, ACUTE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; RISK FACTORS;

EID: 77949908191     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2009.09.072     Document Type: Article

References (47)

1. Marenzi G., Assanelli E., Campodonico J., et al. Contrast volume during primary percutaneous coronary intervention and subsequent contrast-induced nephropathy and mortality. Ann Intern Med 150 (2009) 170-177
2. Marenzi G., Lauri G., Assanelli E., et al. Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. J Am Coll Cardiol 44 (2004) 1780-1785
3. Goldenberg I., and Matetzky S. Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies. CMAJ 172 (2005) 1461-1471
4. Nikolsky E., Mehran R., Turcot D., et al. Impact of chronic kidney disease on prognosis of patients with diabetes mellitus treated with percutaneous coronary intervention. Am J Cardiol 94 (2004) 300-305
5. Levy E.M., Viscoli C.M., and Horwitz R.I. The effect of acute renal failure on mortality. A cohort analysis. JAMA 275 (1996) 1489-1494
6. Rihal C.S., Textor S.C., Grill D.E., et al. Incidence and prognostic importance of acute renal failure after percutaneous coronary intervention. Circulation 105 (2002) 2259-2264
7. McCullough P.A., Wolyn R., Rocher L.L., Levin R.N., and O'Neill W.W. Acute renal failure after coronary intervention: incidence, risk factors, and relationship to mortality. Am J Med 103 (1997) 368-375
8. Gruberg L., Mintz G.S., Mehran R., et al. The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. J Am Coll Cardiol 36 (2000) 1542-1548
9. Sadeghi H.M., Stone G.W., Grines C.L., et al. Impact of renal insufficiency in patients undergoing primary angioplasty for acute myocardial infarction. Circulation 108 (2003) 2769-2775
10. Lindsay J., Apple S., Pinnow E.E., et al. Percutaneous coronary intervention-associated nephropathy foreshadows increased risk of late adverse events in patients with normal baseline serum creatinine. Catheter Cardiovasc Interv 59 (2003) 338-343
11. Malmberg K., Norhammar A., Wedel H., and Ryden L. Glycometabolic state at admission: important risk marker of mortality in conventionally treated patients with diabetes mellitus and acute myocardial infarction: long-term results from the Diabetes and Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) study. Circulation 99 (1999) 2626-2632
12. Dangas G., Iakovou I., Nikolsky E., et al. Contrast-induced nephropathy after percutaneous coronary interventions in relation to chronic kidney disease and hemodynamic variables. Am J Cardiol 95 (2005) 13-19
13. Subramanian S., Tumlin J., and Bapat B. Economic burden of contrast-induced nephropathy: Implications for prevention strategies. J Med Econ 10 (2007) 119-134
14. McCullough P.A. Acute kidney injury with iodinated contrast. Crit Care Med 36 (2008) S204-S211
15. McCullough P.A., Adam A., Becker C.R., et al. Risk prediction of contrast-induced nephropathy. Am J Cardiol 98 Suppl (2006) 27K-36K
16. Deedwania P., Kosiborod M., Barrett E., et al. Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117 (2008) 1610-1619
17. Norhammar A., Tenerz A., Nilsson G., et al. Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359 (2002) 2140-2144
18. Capes S.E., Hunt D., Malmberg K., and Gerstein H.C. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355 (2000) 773-778
19. Kosiborod M., Rathore S.S., Inzucchi S.E., et al. Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111 (2005) 3078-3086
20. Stranders I., Diamant M., van Gelder R.E., et al. Admission blood glucose level as risk indicator of death after myocardial infarction in patients with and without diabetes mellitus. Arch Intern Med 164 (2004) 982-988
21. Wahab N.N., Cowden E.A., Pearce N.J., Gardner M.J., Merry H., and Cox J.L. Is blood glucose an independent predictor of mortality in acute myocardial infarction in the thrombolytic era?. J Am Coll Cardiol 40 (2002) 1748-1754
22. Kosiborod M., Inzucchi S.E., Krumholz H.M., et al. Glucometrics in patients hospitalized with acute myocardial infarction: defining the optimal outcomes-based measure of risk. Circulation 117 (2008) 1018-1027
23. Kosiborod M., Inzucchi S.E., Goyal A., et al. Relationship between spontaneous and iatrogenic hypoglycemia and mortality in patients hospitalized with acute myocardial infarction. JAMA 301 (2009) 1556-1564
24. Kosiborod M., Inzucchi S.E., Krumholz H.M., et al. Glucose normalization and outcomes in patients with acute myocardial infarction. Arch Intern Med 169 (2009) 438-446
25. Mehta R.L., Kellum J.A., Shah S.V., et al. Acute Kidney Injury Network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 11 (2007) R31
26. Levey A.S., Bosch J.P., Lewis J.B., Greene T., Rogers N., Roth D., and Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130 (1999) 461-470
27. Cheung N.W., Napier B., Zaccaria C., and Fletcher J.P. Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition. Diabetes Care 28 (2005) 2367-2371
28. Palomba H., de Castro I., Neto A.L., Lage S., and Yu L. Acute kidney injury prediction following elective cardiac surgery: AKICS score. Kidney Int 72 (2007) 624-631
29. Gandhi G.Y., Nuttall G.A., Abel M.D., et al. Intraoperative hyperglycemia and perioperative outcomes in cardiac surgery patients. Mayo Clin Proc 80 (2005) 862-866
30. Toprak O., Cirit M., Yesil M., et al. Impact of diabetic and pre-diabetic state on development of contrast-induced nephropathy in patients with chronic kidney disease. Nephrol Dial Transplant 22 (2007) 819-826
31. Clavijo L.C., Pinto T.L., Kuchulakanti P.K., et al. Metabolic syndrome in patients with acute myocardial infarction is associated with increased infarct size and in-hospital complications. Cardiovasc Revasc Med 7 (2006) 7-11
32. Kosiborod M., Inzucchi S., Clark B., et al. National patterns of glucose control among patients hospitalized with acute myocardial infarction. J Am Coll Cardiol 49 (2007) 283A
33. Bohlen H.G., and Lash J.M. Topical hyperglycemia rapidly suppresses EDRF-mediated vasodilation of normal rat arterioles. Am J Physiol 265 (1993) H219-H225
34. Bucala R., Tracey K.J., and Cerami A. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest 87 (1991) 432-438
35. Catherwood M.A., Powell L.A., Anderson P., McMaster D., Sharpe P.C., and Trimble E.R. Glucose-induced oxidative stress in mesangial cells. Kidney Int 61 (2002) 599-608
36. Giugliano D., Marfella R., Coppola L., et al. Vascular effects of acute hyperglycemia in humans are reversed by L-arginine. Evidence for reduced availability of nitric oxide during hyperglycemia. Circulation 95 (1997) 1783-1790
37. Marfella R., Quagliaro L., Nappo F., Ceriello A., and Giugliano D. Acute hyperglycemia induces an oxidative stress in healthy subjects. J Clin Invest 108 (2001) 635-636
38. Marfella R., Verrazzo G., Acampora R., et al. Glutathione reverses systemic hemodynamic changes induced by acute hyperglycemia in healthy subjects. Am J Physiol 268 (1995) E1167-E1173
39. Tesfamariam B., and Cohen R.A. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol 263 (1992) H321-H326
40. Trachtman H., Futterweit S., and Crimmins D.L. High glucose inhibits nitric oxide production in cultured rat mesangial cells. J Am Soc Nephrol 8 (1997) 1276-1282
41. Williams S.B., Goldfine A.B., Timimi F.K., et al. Acute hyperglycemia attenuates endothelium-dependent vasodilation in humans in vivo. Circulation 97 (1998) 1695-1701
42. Marfella R., Nappo F., De Angelis L., Paolisso G., Tagliamonte M.R., and Giugliano D. Hemodynamic effects of acute hyperglycemia in type 2 diabetic patients. Diabetes Care 23 (2000) 658-663
43. Melin J., Hellberg O., and Fellstrom B. Hyperglycaemia and renal ischaemia-reperfusion injury. Nephrol Dial Transplant 18 (2003) 460-462
44. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 345 (2001) 1359-1367
45. Schetz M., Vanhorebeek I., Wouters P.J., Wilmer A., and Van den Berghe G. Tight blood glucose control is renoprotective in critically ill patients. J Am Soc Nephrol 19 (2008) 571-578
46. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 354 (2006) 449-461
47. Thomas G., Rojas M.C., Epstein S.K., Balk E.M., Liangos O., and Jaber B.L. Insulin therapy and acute kidney injury in critically ill patients a systematic review. Nephrol Dial Transplant 22 (2007) 2849-2855